Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.
References (7)
- Alam A, Voronovich Z, Carley JA. A review of therapeutic uses of mirtazapine in psychiatric and medical conditions. Prim Care Companion CNS Disord. 2013;15(5):PCC.13r01525. PubMed CrossRef
- Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001;7(3):249–264. PubMed CrossRef
- Lee GH, Stewart JT. A case of musical hallucinations related to mirtazapine. Clin Neuropharmacol. 2018;41(6):222–223. PubMed CrossRef
- Dursun E, Akpinar A, Battal B. Sudden hearing loss associated with mirtazapine therapy: a case report. Klin Psikofarmakol Bul. 2009;19(4):417–419.
- Rizk HG, Lee JA, Liu YF, et al. Drug-induced ototoxicity: a comprehensive review and reference guide. Pharmacotherapy. 2020;40(12):1265–1275. PubMed CrossRef
- Ganesan P, Schmiedge J, Manchaiah V, et al. Ototoxicity: a challenge in diagnosis and treatment. J Audiol Otol. 2018;22(2):59–68. PubMed CrossRef
- Hammill TL, Campbell KC. Protection for medication induced hearing loss: the state of the science. Int J Audiol. 2018;57(suppl 4):S67–S75. PubMed CrossRef
Buy PDF for $40
Please sign in or purchase this PDF for $40.
Save
Share
Cite
